Brand profile · Pharmaceutical Manufacturing

ChemLex

ChemLex works in Pharmaceutical Manufacturing, out of Singapore. Ownership is privately held; it publishes at chemlex.com. It holds one address on record, all in Singapore. The record counts 29 people. One Singapore registration (UEN) is a confirmed match. The latest round on record is Series A at US$33.5M. The record links four similar brands, most of them in Biotechnology Research.

LinkedIn

Profile live Privately Held Founded 2022 1 entity UEN 1 office country US$ 33.5M Series A
Registry verified · ACRA
Counted staff
29
self-reported band not used
Founded
2022
4 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
2
Series A · May 2025 · US$ 33.5M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

ChemLex: 1 registry entityChemLex is linked to 1 registry entity: CHEMLEX PTE. LTD. (UEN 202405643R, confirmed).ChemLexCHEMLEX PTE. LTD.UEN 202405643RConfirmed · ACRA
Show as table
CHEMLEX PTE. LTD.UEN 202405643R
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

ChemLex is a Singapore-based company delivering autonomous chemical synthesis services for the pharmaceutical and biotech industry. Our AI-integrated autonomous synthesis platform improves quality, consistency, and productivity while reducing costs and supporting ESG goals.

Locations

Singaporeprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table
Countries1
Primary countrySG

All codes: SG

Addresses

  • SGSingapore, SingaporePrimary

Grid intelligence Members

Funding

Last round · 17 May 2025US$ 33.5MSeries A
Rounds2
Round typeSeries A · venture round
Amount (USD)33,500,000
Stage rank3
Investors named0
Since last round8 mo

Funding

2 funding roundsFunding timeline. Latest round 17 May 2025: Series A, US$ 33.5M.20222026Series AUS$ 33.5M2 rounds
Show as table
Rounds2
Axis2022 to 2026
Series A · 17 May 2025US$ 33.5M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under ChemLex?

One Singapore entity on ACRA. CHEMLEX PTE. LTD. (UEN 202405643R), high confidence.

How many people work at ChemLex?

The record holds 29 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.

Where does ChemLex have offices?

One address on record, Singapore only. Primary: Singapore.

Has ChemLex raised funding?

Two rounds. Latest 17 May 2025: Series A, US$33,500,000.

Which companies are listed alongside ChemLex?

Four peer profiles on record: Granite Asia and ChemT Biotechnology.